
|Videos|May 10, 2018
Placebo may be as good as omega-3s according to DREAM study findings
Author(s)Penny Asbell, MD
Penny Asbell, MD, professor of ophthalmology at Mount Sinai in New York, NY, discusses the Dry Eye Assessment and Management Study (DREAM) study and why omega-3s may be no better than a placebo in helping dry eye at ARVO 2018 in Honolulu.
Advertisement
The views expressed here belong to the author. They do not necessarily represent the views of Optometry Times or UBM Medica.
Penny Asbell, MD, professor of ophthalmology at Mount Sinai in New York, NY, discusses the Dry Eye Assessment and Management Study (DREAM) study and why omega-3s may be no better than a placebo in helping dry eye at ARVO 2018 in Honolulu.
Newsletter
Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Systematic review finds driving negatively impacted by glaucomatous VF defects
2
2025 takes dry eye, presbyopia by storm
3
BLA accepted, priority review granted by US FDA for Viridian Viridian Therapeutics’ veligrotug
4
Crafting your own eyewear brand: An introduction to Sho Eyeworks and brand profitability
5












































